$10 Billion Deal, page-12908

Lol. Its not you btw mate. I think its as you say a lot here, I suspect mainly the non holders, its not all non holders though.

To your point re deference

Dr Stephen Becker, MD Chief Medical Officer
Dr Michelle Miller, BSc, MSc, PhD GCertAppFin (Finsia)Chief Executive Officer and Managing Director
Dr Susan M Pond AM, MD DSc, FTSE FAHMSIndependent and Non-Executive Director
Prof Stephen Locarnini AM, BSc(Hons), PhD, MBBS, FRC(Path)Independent and Non-Executive Director

https://www.biotron.com.au/about-us/management/
https://www.biotron.com.au/about-us/board/

Its not that hard to reverse engineer the mathematics of the results, and see why they're prepared to sign off on wording, even with the regulatory requirement not to overstate, per post last week. I think the 11's will be even better, pretty much what they inferred in Jan. Interesting they ran the 10's first.

Biotron Limited (‘Biotron’ or ‘the Company’) has achieved key outcomes including:
 Reported positive outcomes from the BIT225-010 Phase 2 HIV-1 clinical trial, with all primary
objectives of the trial met.
 Continued detailed post-clinical phase activities and analyses of the BIT225-011 Phase 2 clinical
trial of BIT225.
 Continued detailed post-clinical phase activities and analyses of the BIT225-012 Phase 2 clinical
trial of BIT225 for treatment of adults with COVID-19.